The Level of Plasma Amyloid-β40 Is Correlated with Peripheral Transport Proteins in Cognitively Normal Adults: A Population-Based Cross-Sectional Study.

Ling Gao,Yu Jiang,Shan Wei,Suhang Shang,Pei Li,Chen Chen,Liangjun Dang,Jin Wang,Kang Huo,Meiying Deng,Jingyi Wang,Rong Zhang,Qiumin Qu
DOI: https://doi.org/10.3233/JAD-180399
2018-01-01
Journal of Alzheimer s Disease
Abstract:Background: Transport proteins, soluble low-density lipoprotein receptor-related protein-1 (sLRP1), and soluble receptor of advanced glycation end products (sRAGE), play an important role in the clearance of plasma amyloid-beta (A beta). However, their relationship is not clear. Objective: The aim was to explore the relationship between plasma levels of sLRP1, sRAGE, and A beta in a cross-sectional study. Methods: A total of 1,185 cognitively normal participants (age above 40) from a village in the suburbs of Xi' an, China were enrolled from October 8, 2014 to March 30, 2015. Plasma A beta(40), A beta(42), sLRP1, and sRAGE were tested using a commercial ELISA. Apolipoprotein E (APOE) genotyping was conducted using PCR and sequencing. The relationship between plasma levels of sLRP1, sRAGE, and A beta was analyzed using Pearson's correlation analysis and multiple linear regression. Results: In the total population, Log sLRP1 and Log sRAGE were positively correlated with plasma A beta(40) (r = 0.103, p <0 .001; r = 0.064, p = 0.027, respectively), but neither were associated with plasma A beta(42). After multivariable adjustment in the regression model, Log sLRP1 and Log sRAGE were still positively related with plasma A beta(40) (beta = 2.969, p <0.001; beta= 1.936, p = 0.017, respectively) but not A beta(42). Furthermore, the positive correlations between transport proteins and plasma A beta(40) remained significant only in APOE epsilon 4 non-carriers after Pearson's analysis and multiple regression analysis after stratification by gene status. Conclusion: The concentrations of plasma sLRP1 and sRAGE had a significant impact on the level of plasma A beta(40) in cognitively normal adults, especially in APOE epsilon 4 non-carriers. However, the mechanism by which the transport proteins are involved in peripheral A beta clearance and the relationship between transporters and amyloid burden in the brain needs further validation.
What problem does this paper attempt to address?